Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) will likely be releasing its results after the market closes on Friday, July 31st. Analysts expect the company to announce earnings of $0.2608 per share and revenue of $3.3434 billion for the quarter. Daiichi Sankyo has set its FY 2026 guidance at 0.910-0.910 EPS.
Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) last issued its quarterly earnings results on Monday, May 11th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.33 by ($0.18). The company had revenue of $3.76 billion during the quarter, compared to the consensus estimate of $3.74 billion. Daiichi Sankyo had a return on equity of 15.75% and a net margin of 12.32%. On average, analysts expect Daiichi Sankyo to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Daiichi Sankyo Stock Down 1.0%
DSNKY stock opened at $17.70 on Thursday. Daiichi Sankyo has a 52 week low of $14.98 and a 52 week high of $27.50. The business has a 50-day simple moving average of $16.49 and a 200 day simple moving average of $17.78. The company has a quick ratio of 1.64, a current ratio of 2.42 and a debt-to-equity ratio of 0.18. The company has a market cap of $32.97 billion, a PE ratio of 18.83, a price-to-earnings-growth ratio of 3.13 and a beta of -0.17.
Analysts Set New Price Targets
View Our Latest Report on Daiichi Sankyo
About Daiichi Sankyo
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
Featured Stories
- Five stocks we like better than Daiichi Sankyo
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
